(Q37605801)

21 August 2017

1 reference

title

Bosentan: a review of its use in the management of mildly symptomatic pulmonary arterial hypertension (English)

1 reference

21 August 2017

2

Gillian M Keating

1 reference

21 August 2017

1

Sohita Dhillon

1 reference

21 August 2017

publication date

1 January 2009

1 reference

American journal of cardiovascular drugs

21 August 2017

published in

1 reference

21 August 2017

volume

9

1 reference

21 August 2017

issue

5

1 reference

21 August 2017

page(s)

331-350

1 reference

https://scigraph.springernature.com/pub.10.2165/11202270-000000000-00000

21 August 2017

exact match

0 references

cites work

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

1 reference

https://api.crossref.org/works/10.2165%2F11202270-000000000-00000

Primary pulmonary hypertension. A national prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11202270-000000000-00000

Pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11202270-000000000-00000

Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11202270-000000000-00000

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11202270-000000000-00000

10.2165/11202270-000000000-00000

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

21 August 2017

1011180779

0 references

1 reference